Corporate News     24-Aug-23
USFDA classifies Ipca Lab's Silvassa unit inspection as Voluntary Action Indicated
Ipca Laboratories has received a communication from US FDA that they have determined the inspection classification of the company's Piparia (Silvassa) formulations manufacturing facility as “Voluntary Action Indicated (VAI).

Based on this inspection, this facility is considered to be in a minimally acceptable state of compliance with regards to current good manufacturing practice (CGMP).

Previous News
  Ipca Laboratories consolidated net profit rises 0.81% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   15:07 )
  Ipca Laboratories Ltd gains for fifth session
 ( Hot Pursuit - 12-Aug-24   13:00 )
  Volumes jump at CreditAccess Grameen Ltd counter
 ( Hot Pursuit - 23-Oct-23   14:30 )
  Ipca Laboratories Ltd soars 0.42%, up for fifth straight session
 ( Hot Pursuit - 02-Jan-24   13:00 )
  Ipca Laboratories schedules board meeting
 ( Corporate News - 21-Jan-23   10:11 )
  Ipca Laboratories consolidated net profit declines 12.72% in the March 2020 quarter
 ( Results - Announcements 16-Jun-20   14:05 )
  Ipca Laboratories Ltd up for third straight session
 ( Hot Pursuit - 11-Jan-24   13:05 )
  Ipca Laboratories Ltd spurts 1.67%, gains for five straight sessions
 ( Hot Pursuit - 06-Jul-22   13:00 )
  Ipca Labs hits 52-week low on plan to acquire stake in Unichem
 ( Hot Pursuit - 25-Apr-23   11:11 )
  Ipca Laboratories receives credit ratings from ICRA
 ( Corporate News - 27-Sep-22   16:28 )
  Ipca Laboratories standalone net profit rises 113.35% in the March 2019 quarter
 ( Results - Announcements 31-May-19   08:23 )
Other Stories
  Anmol India to conduct board meeting
  03-Oct-24   10:07
  KPI Green Energy receives CEIG approval for 5 MW solar power project
  03-Oct-24   10:04
  Navkar Corporation revises board meeting date
  03-Oct-24   09:52
  Paytm deploys card machines across 2 Krishi Mandis in Madhya Pradesh
  03-Oct-24   09:52
  Adani Ports records 14% growth in cargo volumes in September 2024
  03-Oct-24   09:37
  SignatureGlobal India launches new project in Gurugram
  03-Oct-24   09:34
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
  03-Oct-24   09:29
  RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
  03-Oct-24   09:26
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
  03-Oct-24   09:23
  Transformers & Rectifiers India wins order of Rs 565 cr
  03-Oct-24   09:07
Back Top